STEM CLASS ACTION LAWSUIT The Stem class action lawsuit seeks to represent purchasers or acquirers of Stem, Inc. (“Stem”) f/k/a Star Peak Energy Transition Corp. (NYSE: STEM; STEM.WS) securities: (a) pursuant and/or traceable to the offering documents issued in connection with the merger consummated on April 28, 2021 by and among Stem, Star Peak Energy Transition Corp. Merger Sub Corp., and Stem, Inc., a private Delaware corporation (“Legacy Stem”); and/or (b) between March 4, 2021 and February 16, 2023, inclusive (the “Class Period”). Captioned Petersen v. Stem, Inc. f/k/a Star Peak Energy Transition Corp., No. 23-cv-02329 (N.D. Cal.), the Stem class action lawsuit charges Stem and certain of Stem’s top current and former executives and directors with violations of the Securities Act of 1933 and/or Securities Exchange Act of 1934. If you suffered losses in Stem stock and wish to serve as lead plaintiff in the class action against Stem, please provide your information below. You can also contact Stem Stock Loss Lawyer Timothy L. Miles by calling 855/846-6529 or via e-mail at tmiles@timmileslaw.com. You can also contact Stem Stock Loss Lawyer Timothy L. Miles by calling 855/846-6529 or via e-mail at tmiles@timmileslaw.com. Lead plaintiff motions for the Stem class action lawsuit must be filed with the court no later than July11, 2023. CONTACT The Law Offices of Timothy L. Miles Tapestry at Brentwood Town Center 300 Centerview Dr., #247 Brentwood, TN 37027 Phone: (855) 846-6529 Email: tmiles@timmileslaw.com
from
https://www.youtube.com/watch?v=78l3tmHSJ7k
Subscribe to:
Post Comments (Atom)
AUTODESK CLASS ACTION LAWSUIT
The Autodesk class action lawsuit seeks to represent purchasers or acquirers of Autodesk, Inc. (NASDAQ: ADSK) publicly traded securities bet...
-
JUUL ADDICTION LAWSUIT from https://www.youtube.com/watch?v=hDwYmVVvxJE
-
Top Workers Compensation Attorney Nashville from https://www.youtube.com/watch?v=rbSDfQqLZdo
-
NASHVILLE OZEMPIC LAWYER LAW OFFICES OF TIMOTHY L. MILES (855) 846-6529 | tmiles@timmileslaw.com WHAT ABOUT OZEMPIC AND PANCREATITIS? FROM A...
No comments:
Post a Comment